CSIMarket


Genmark Diagnostics Inc   (GNMK)
Other Ticker:  
 


 

Genmark Diagnostics Inc

GNMK's Financial Statements and Analysis



Genmark Diagnostics Inc narrowed forth quarter of 2020 net loss per share of $-0.05 compare to net loss per share of $-0.17 recorded in the same quarter a year ago a decrease compare to $-0.05 realized in previous quarter.


forth quarter of 2020
Earnings Per Share Revenues
$ -0.05 $  50 Mill
$+0.12     $+23M     +84.14 %



Genmark Diagnostics Inc 's Revenue rose by 84.14 % in forth quarter of 2020 (Dec 31 2020) year on year, to $50 million and advanced by 17.43 % sequentially.


Genmark Diagnostics Inc is

More on GNMK's Income Statement



Genmark Diagnostics Inc 's in theforth quarter of 2020 recorded net loss of $-3.724 million, an improvement compare to net loss of $-10.287 million in IV. Quarter a year ago.

Sequentially net loss advanced

More on GNMK's Growth

Genmark Diagnostics Inc Inventories
Inventories grew by 88.68 % to $21 million from IV. Quarter a year ago, sequentially inventories rose by 8.96 %. In Dec 31 2020 company's net cash and cash equivalents decreased by $-17 million, capital expenditures fell by -0.8991,001.45%, to $-10 millions compare to same quarter a year ago

More on GNMK's Cash flow Statement


Genmark Diagnostics Inc does not pay out common stock dividend.

In trailing twelve-month period Genmark Diagnostics Inc earned $ 0.09 cash per share, on a free-cash flow basis .

Book value fell by -0.81 % sequentially to $1.31 per share, -3.66% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ 1.30 per share from $ 1.24.

Company issued 0.76 million shares or 1.07 % in Dec 31 2020.


More on GNMK's Dividends

 Market Capitalization (Millions) 1,728
 Shares Outstanding (Millions) 72
 Total Debt (Millions $) 71
 Revenue (TTM) (Millions $) 172
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) -18
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 357




Genmark Diagnostics Inc does not pay out common stock dividend.

In trailing twelve-month period Genmark Diagnostics Inc had $ 0.09 cash flow per share, on a free-cash flow basis .

Book value fell by -0.81 % sequentially to $1.31 per share, -3.66% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ 1.30 per share from $ 1.24.

Company issued 0.76 million shares or 1.07 % in Dec 31 2020.


More on GNMK's Balance Sheets

 Market Capitalization (Millions) 1,728
 Shares Outstanding (Millions) 72
 Total Debt (Millions $) 71
 Revenue (TTM) (Millions $) 172
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) -18
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 357
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com